( >This continuing evolution of the CIO'...)Now comes the hybrid CIO
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Now comes the hybrid CIO
> This continuing evolution of the CIO's role begs the following question: Does today's hybrid CIO really represent yet another way of demoting the CIO and technology function? Weve struggled for so long to have the CIO report directly to the CEO. Just when we think weve achieved it, the CIO morphs into something that we dont quite recognize and without the true technology believers fire in his or......
Full article >>>
'"/>
Source:wistechnology.com By Byron Glick 11/16/05
Related biology technology :
1. A Midwest life-science odyssey comes full circle
2. Daugherty becomes CTO of Great Lakes BioFuels
3. Report card praises Wisconsin economy, but comes with warning
4. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
5. Cloning ban comes before Wisconsin Senate on Tuesday
6. Women in technology confab comes to Wisconsin
7. Historic observatory becomes hot property on Lake Geneva
8. Online matchmaking comes to the boardroom
9. Christmas comes early with Treo 650
10. DataPod becomes BeInSync so you can, too
11. Instant messaging comes to groups
Post Your Comments:
Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3
[0] NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont [0] YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT[0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products[0] Martek Signs Sole-Source Supply Agreement with Fonterra
Other Biology Technology:West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6/C O R R E C T I O N -- Rosetta Genomics Ltd/ 7/C O R R E C T I O N -- Rosetta Genomics Ltd/ 8/C O R R E C T I O N -- Rosetta Genomics Ltd/ 9/C O R R E C T I O N -- Rosetta Genomics Ltd/ 10/C O R R E C T I O N -- Rosetta Genomics Ltd/ 11/C O R R E C T I O N -- Rosetta Genomics Ltd/ 12/C O R R E C T I O N -- Rosetta Genomics Ltd/ 13/C O R R E C T I O N -- Rosetta Genomics Ltd/ 14/C O R R E C T I O N -- Rosetta Genomics Ltd/ 15/C O R R E C T I O N -- Rosetta Genomics Ltd/ 16/C O R R E C T I O N -- Rosetta Genomics Ltd/ 17/C O R R E C T I O N -- Rosetta Genomics Ltd/ 18/C O R R E C T I O N -- Rosetta Genomics Ltd/ 19/C O R R E C T I O N -- Rosetta Genomics Ltd/ 20
Breaking Biology News(10 mins):Climate projections underestimate CO2 impact 2UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2Reliv Foundation Builds Feeding Center and School for Impoverished People in Haiti 50940 1Reliv Foundation Builds Feeding Center and School for Impoverished People in Haiti 50940 2Reliv Foundation Builds Feeding Center and School for Impoverished People in Haiti 50940 3Knowing Yourself Can Improve Your Health and Happiness 50937 1Knowing Yourself Can Improve Your Health and Happiness 50937 2Knowing Yourself Can Improve Your Health and Happiness 50937 3Genes Linked to Cholesterol in Cells Are Identified 50935 1Genes Linked to Cholesterol in Cells Are Identified 50935 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |